MedPath

Comparing The Effectiveness of Acceptance and Commitment Therapy,Pharmacotherapy.and their combination in the Treatment of Obsessive-Compulsive Disorder

Not Applicable
Conditions
Obsessive Compulsive Disorder.
Obsessive-compulsive disorder
Registration Number
IRCT2013042713145N1
Lead Sponsor
Tehran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Inclusion criteria : a primary diagnosis of OCD according to DSM-IV-TR ; age between 18 to 50 years; OCD symptoms duration of at least 1year; Exclusion criteria: having a current or past psychotic disorder ; suicidal tendencies; medical illness ; substance abuse disorder ; personality disorder; had been treated with either pharmacotherapy or psychotherapy in the 1month preceding baseline;patients with other axis I disorders (except anxiety disorders and major depression disorder and dysthymia disorder) and axis II disorders

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Obsessive - compulsive symptoms. Timepoint: pre-middle and post-treatment. Method of measurement: The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).
Secondary Outcome Measures
NameTimeMethod
Depression. Timepoint: pre-middle and post treatment(tenth week). Method of measurement: Beck Depression Inventory-II-Second Edition (BDI-II).;Anxiety. Timepoint: pre-middle and post treatment(tenth week). Method of measurement: Beck Anxiety Inventory (BAI).;Experiential avoidance. Timepoint: pre-middle and post treatment(tenth week). Method of measurement: Acceptance and Action Questionnaire (AAQ).;Quality of Life. Timepoint: pre-and post treatment(tenth week). Method of measurement: World Health Organization Quality of Life-BREF (WHOQOL-BREF).
© Copyright 2025. All Rights Reserved by MedPath